Skip to main content

FDA Allows Emergency Use Of Regeneron Antibody Drug Trump Received For COVID-19

NewsColony
FDA Allows Emergency Use Of Regeneron Antibody Drug Trump Received For COVID-19

(AP) — U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.

The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.

The drug is given as a one-time treatment through an IV. The FDA allowed its use in adults and children 12 and over who weigh at least 88 pounds (40 kilograms) and who are at high risk of severe illness from COVID-19 because of age or certain other medical conditions.

Emergency authorization allows use of the drug to start while studies are continuing to establish safety and effectiveness. Early results suggest the drug may reduce COVID-19-related hospitalization or emergency room visits in patients at high risk for disease progression, the FDA said.

Regeneron said that initial doses will be made available to roughly 300,000 patients through a federal government allocation program. Patients will not be charged for the drug but may have to pay part of the cost of giving the IV.

Initial supplies will likely be vastly outstripped by demand as the U.S. has surged past 10 million reported cases, with the country facing what health experts say will be a dark winter due uncontrolled spread of the virus.

Antibodies are proteins the body makes to target and help eliminate viruses, but it can take weeks for the best ones to form after an infection occurs. The drugs are concentrated versions of ones that proved best able to do this in lab and animal tests, and in theory help the body start to fight the virus right away.

The Regeneron drug is a combo of two antibodies to enhance the chances it will prove effective. Earlier this month, the FDA gave emergency authorization to a single-antibody drug from Eli Lilly that also is still being studied.

There’s no way to know whether the Regeneron drug helped Trump recover; he received a host of treatments and most COVID-19 patients recover on their own.

FDA regulators authorized the Regeneron drug using their emergency powers to quickly speed the availability of experimental drugs and other medical products during public health crises.

In normal times the FDA requires “substantial evidence” to show that a drug is safe and effective, usually through one or more large, rigorously controlled patient studies. But during public health emergencies the agency can lower those standards and require only that an experimental treatment’s potential benefits outweigh its risks.

The emergency authorization functions like a temporary approval for the duration of the COVID-19 pandemic. To win full approval, Regeneron will have to submit additional research to fully define the drug’s safety and benefit for patients.

(Copyright 2020 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

Also From CBS Chicago:

Source: CBS Chicago | News Colony

The post FDA Allows Emergency Use Of Regeneron Antibody Drug Trump Received For COVID-19 appeared first on NewsColony.
NewsColony



source https://newscolony.com/fda-allows-emergency-use-of-regeneron-antibody-drug-trump-received-for-covid-19/

Comments

Popular posts from this blog

Volunteers book hotel room for homeless man with SingapoRediscovers vouchers

NewsColony Volunteers book hotel room for homeless man with SingapoRediscovers vouchers © The Independent Singapore Singapore — A group of volunteers from the Mummy Yummy Singapore welfare organisation donated their SingapoRediscovers Vouchers to book a hotel room for a homeless man. The man, who was identified as Jayden, did not have a place to live while waiting for the Housing Board (HDB) to allocate him a rental flat. In a Facebook post on Mummy Yummy Singapore’s page on Wednesday (Dec 16), the volunteers said: “We used our $100 Rediscover Singapore vouchers to redeem hotel stay for him and successfully booked 9 days worth of stay at 3 days per voucher.” They added that they were unable to book a longer stay because of higher hotel rates over Christmas and New Year. The volunteers hoped that they would be able to bridge Jayden’s stay until he got a flat. “Thanks our government for giving us these vouchers which in return we can put them to good use for people in need,” th...

17 gifts from Oprah’s Favorite Things you can get by Christmas

NewsColony 17 gifts from Oprah’s Favorite Things you can get by Christmas (CNN) —   Oprah Winfrey has pretty impeccable taste, and this year, she’s gifted us once again with her Favorite Things list, available to shop via Amazon . We’ve gone through and pulled out some of our own favorite picks from the list, which features products for everyone on your holiday gift list at a range of prices. And while, obviously, it’s Oprah, so everything included is great, we especially love her picks from Black- and female-owned small businesses. Check out our top gift picks below, and browse all of Oprah’s Favorite Things on Amazon. Iconi Women’s Seamless High-Waisted Leggings ($45; amazon.com ) Iconi Women’s Seamless High-Waisted Leggings PHOTO: Amazon These comfortable leggings are designed to be everything you’ve always wanted in a pair: moisture-wicking, supportive and squatproof. Plus, they come in a ton of pretty heathered colors. “A Kids Book About…” ($15.96; amazon.c...

Books Reviewed in 2020

NewsColony Books Reviewed in 2020 2020 was a terrible year for the world. 2020 was a great year for books. Here are the books that I reviewed for IHE, along with a couple that I co-authored. Would love to hear (in a letter to the editor, or an e-mail, or a tweet, or a TikTok, or whatever) if we read any of the same books in 2020. See you all in 2021. Learning Innovation and the Future of Higher Education by Joshua Kim and Edward Maloney The Low-Density University: 15 Scenarios for Higher Education by Edward Maloney and Joshua Kim Foreword to ‘Going Alt-Ac: A Guide to Alternative Academic Careers’: An introduction to a must-read new book. The authors of Going Alt-Ac: A Guide to Alternative Academic Careers , Kathryn E. Linder, Kevin Kelly and Thomas J. Tobin, asked me to write the foreword to their book. https://www.insidehighered.com/blogs/learning-innovation/foreword-%E2%80%98going-alt-ac-guide-alternative-academic-careers%E2%80%99 Universities, the Climate Emergency, and ...